A Phase I Study of Lapatinib and Cetuximab in Patients With Solid Tumors.

Trial Profile

A Phase I Study of Lapatinib and Cetuximab in Patients With Solid Tumors.

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Jan 2015

At a glance

  • Drugs Cetuximab (Primary) ; Lapatinib (Primary)
  • Indications Colorectal cancer; Head and neck cancer; Non-small cell lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 01 Sep 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Feb 2013 Planned End Date changed from 1 Oct 2013 to 1 Oct 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top